Global Hyperpigmentation Treatment Market Opportunities and Forecast 2023-2030

Hyperpigmentation Treatment Market Overview

The global Hyperpigmentation Treatment market is expected to grow at a moderate rate during the forecast period. Huge growth in aging population and rise in incidence of skin disorders is boosting the growth of the global healthcare biometric market. Surge in demand for the skin lightening to expand the growth of the market.
 
Moreover, governments in many countries are supporting and taking initiatives for the adoption of hyperpigmentation in the healthcare sector is the important factor expected to boost the growth of the Hyperpigmentation Treatment market in near future. In addition to this, growing health care expenditure is further driving the expansion of this market globally.
 
On the other hand, a lack of awareness among patients regarding hyperpigmentation and the high cost of treatment for healthcare along with the challenges associated with treatment options is likely to hamper the global Hyperpigmentation Treatment market during the forecast period.
 
Covid-19 Impact on Hyperpigmentation Treatment Market:
 
In addition, the current Hyperpigmentation Treatment Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Hyperpigmentation Treatment Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
 
Hyperpigmentation Treatment Market Segment Overview

According to Treatment Type, the market is segmented into Pharmacological therapy, and Non-pharmacological/Cosmetic Therapy. Among these Pharmacological therapy holds the largest share of the market mainly because these include, hydroquinone, topical corticoids (steroids), azelaic acid, ascorbic acid (vitamin c), kojik acid, liquorice extract and citrus extracts. Prescription medications that can be given during hyperpigmentation which are the primary treatment offered to the patient and hence would contribute towards highest revenue share of the hyperpigmentation treatment market during the forecast period.

Based on Sales Channel, the Skin Clinics, Drug & Cosmetic Stores, and Hypermarkets & Supermarkets. Skin Clinics segment are expected to grow at the highest rate in the coming years. This owes to the presence of advanced methods for the treatment of hyperpigmentation in the segment, and rise in investment for innovative and cost effective methods adopted in skin clinics, thus it boosting the demand for Hyperpigmentation Treatment globally.

Market Analysis, Insights and Forecast – By Treatment Type
·       Pharmacological therapy
·       Non-pharmacological/Cosmetic Therapy

Market Analysis, Insights and Forecast – By Sales Channel
·       Skin Clinics
·       Drug and Cosmetic Stores
·       Hypermarkets and Supermarkets

Hyperpigmentation Treatment Market Regional Overview

Region-wise, North America dominated the global Hyperpigmentation Treatment market and is expected to continue its dominance during the forecast period. Factors such as the rising number of ageing population, and high health care expenditure propels the growth of the market in North America. Similarly, Asia Pacific is also expected to account for the fastest growth in the global market owing to well-established health care infrastructure. Factors such as development in the health care infrastructure, rising awareness about health, a surge in investment in pharmaceuticals and biotechnology sectors, and growing adoption of hyperpigmentation treatment are expected to escalate the growth of the Hyperpigmentation Treatment market in the Asia Pacific region.

Hyperpigmentation Treatment Market, By Geography
 
·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Hyperpigmentation Treatment Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Hyperpigmentation Treatment are highlighted below.
 
·       There has been a steep growth in research for bringing up cost-effective treatment alternatives for hyperpigmentation. For instance, as per the National Clinical Trials (NCT) registry, as of June 18, 2020, Incyte Corporation is conducting a clinical trial for Ruxolitinib in the treatment of Vitiligo which is in phase II development in the U.S. 

Hyperpigmentation Treatment Market, Key Players

·       Biocosmetic Research Labs
·       Episciences, Inc.
·       Vivier Pharma, Inc.
·       La Roche-Posay
·       Pierre Fabre Dermo Cosmetique
·       Bayer AG
·       Alvogen, Inc.
·       Allergan, Inc.
·       Obagi Medical Products Inc.
·       SkinCeuticals International
·       L’oréal Paris.